ISABS: Personalized Medicine Conference With Nobel Laureates to Be Held in Split, Croatia

Food and Healthcare Press Releases Monday February 18, 2019 08:37
SPLIT, Croatia--18 Feb--PRNewswire/InfoQuest

International Society for Applied Biological Sciences (ISABS), Mayo Clinic and St. Catherine Hospital are organizing "11th ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine"(http://www.isabs.net) in Split, Croatia, June 17th - June 22th, 2019. The Conference is supported by The American Academy for Forensic Sciences and conference topics include: Personalized and regenerative medicine, pharmacogenomics, molecular diagnostics, stem cell therapy, epigenetics, biobanking, microbiome, cancer genetics, immunotherapy, forensic and anthropological genetics, ancient DNA analysis, etc.

To view the Multimedia News Release, please click: https://www.multivu.com/players/uk/8494251-isabs-medicine-conference-in-split-croatia/

More than 50 invited speakers from Mayo Clinic, Harvard Medical School, Columbia University, Princeton University, University of Pennsylvania, MIT, Duke University, Max-Planck-Institute, Case Western Reserve University, Penn State University, Wistar Institute, George Washington University, Erasmus MC University, etc., as well as 500 participants will attend the Conference. Three Nobel Lectures will be given by prof. Robert Huber (Max Planck Institute of Biochemistry), prof. Avram Hershko (Technion), prof. Paul Modrich (Duke University).

Prof. Dragan Primorac, ISABS President said: "The future of medicine will rely on personalized treatments. During ISABS 2019 Conference we will envision the power and advances of personalized medicine that will create significant value for the healthcare system. Bringing together internationally renowned scientists to facilitate research and education of young scientists in individualized medicine speaks volumes about our dedication. We will also discuss significant progress in forensic and anthropological genetics in the last years."

International Society for Applied Biological Sciences (ISABS) is the Association of the American Academy of Forensic Sciences and a leading society in forensic, anthropologic genetics and personalized medicine. ISABS Scientific Committee comprises four Nobel Laureates and world's top physicians and scientists.

According to U.S. News & World Report, Mayo Clinic is the #1 hospital overall and in more specialties that any other US hospital.
St. Catherine Hospital is a European center of excellence and the first European hospital to be awarded "Global Healthcare Accreditation".
Royal Philips, leading health technology company, is enabling patient-specific care with first-time-right decision-making and targeted therapy.
More information on "11th ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine" are available at http://www.isabs.net
Contact:
ISABS 2019 Organizing Committee
info@isabs.hr
Severina Evic
info@isabs.hr
Mobile: +385-91-244-55-89
(Photo: https://mma.prnewswire.com/media/819639/International_Society_for_Applied_Biological_Sciences.jpg )
Source: International Society for Applied Biological Sciences (ISABS)

Latest Press Release

BREASTFEEDING CAMPAIGN SETS A NEW REGIONAL STANDARD FOR SUSTAINABLE COMMUNICATION

The "6 months mother's milk is all you need" campaign has been awarded South East Asia PR Campaign of the year and Cause related public awareness campaign of the Year by Campaign Asia at the PR awards in Hong Kong last month. Initiated by Save The...

Daewoong Pharmaceutical participated in the IMCAS Asia 2019 to introduce the excellence of NABOTA

Daewoong Pharmaceutical Co., Ltd, a world-leading botulinum toxin manufacturer in Korea, announced its participation in IMCAS Asia 2019 held in Bali, Indonesia July 5-7, 2019 to introduce the excellence of NABOTA(R) (Prabotulinumtoxin A). The 13th year...

ISTH Announces Launch Of New Global Education Initiative In Gene Therapy For Hemophilia

The International Society on Thrombosis and Haemostasis (ISTH) is pleased to announce the official launch of Gene Therapy in Hemophilia: An ISTH Education Initiative. This landmark launch, the first of its kind in hemophilia, will take place during the...

Open nursing course to accelerate the safe practice of Peripheral Intravenous Cannula Insertion

"Peripheral Intravenous Cannula Insertion is a very broad term and not likely to be understood by people outside the medical community. In simple terms, it means the provision of saline, medication or blood products through an intravenous device and...

Sirtex Medical reaches milestone 100,000th patient dose delivery of SIR-Spheres(R) Y-90 resin microspheres

- Physicians and employees recognized for their role in this milestone and impact made on patient lives Sirtex Medical, a leading manufacturer of targeted liver cancer therapies, today announced delivery of the 100,000th patient dose of SIR-Spheres(R)...

Related Topics